Bumper Offer - Urjas oil Just @ Rs. 1 X
HB 29 Tablet is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Iron Deficiency Anemia. Other than this, HB 29 Tablet has some other therapeutic uses, which have been discussed ahead.
The correct dosage of HB 29 Tablet depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Some other side effects of HB 29 Tablet have been listed ahead. Usually, these side effects of HB 29 Tablet go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of HB 29 Tablet is Safe for pregnant women and Safe for women who are breastfeeding. It is important to know if HB 29 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the HB 29 Tablet related warnings section.
Other contraindications of HB 29 Tablet have been discussed in the sections ahead.
Additionally, HB 29 Tablet may also adversely react with other medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that HB 29 Tablet is safe while driving, and is is addictive in nature.
HB 29 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when HB 29 Tablet is used -
Moderate
Mild
Is the use of HB 29 Tablet safe for pregnant women?
Hb 29 is safe to take during pregnancy.
Is the use of HB 29 Tablet safe during breastfeeding?
Hb 29 does not show any harmful effects in lactating women.
What is the effect of HB 29 Tablet on the Kidneys?
In the absence of any research, there are no known side effects of Hb 29 on kidneys.
What is the effect of HB 29 Tablet on the Liver?
Hb 29 can cause side effects that could harm the liver. So medical advice before taking it is necessary.
What is the effect of HB 29 Tablet on the Heart?
Hb 29 can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
HB 29 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take HB 29 Tablet unless your doctor advises you to do so -
Is this HB 29 Tablet habit forming or addictive?
No, there is no any evidence that HB 29 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking HB 29 Tablet as it does not make you drowsy.
Is it safe?
HB 29 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
HB 29 Tablet is unable to treat or cure mental disorders.
Interaction between Food and HB 29 Tablet
HB 29 Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and HB 29 Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking HB 29 Tablet with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; INFeD® (Iron dextran)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 604